Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moderna, Inc.

30.97
-0.2900-0.93%
Post-market: 31.050.0800+0.26%19:59 EDT
Volume:5.77M
Turnover:181.03M
Market Cap:11.98B
PE:-3.55
High:32.07
Open:31.53
Low:30.88
Close:31.26
Loading ...

Moderna Inc. Stock Rallies 4.4%, Outperforms Competitors

Dow Jones
·
25 Jun

US CDC's report shows no evidence linking thimerosal-containing vaccines and autism

Reuters
·
24 Jun

Bernstein Keeps Their Hold Rating on Moderna (MRNA)

TIPRANKS
·
20 Jun

Market Chatter: RFK Jr. Weighs Panel Scrutiny of Aluminum in Vaccines

MT Newswires Live
·
18 Jun

US Cdc's Advisory Committee on Immunization Practices to Discuss Mmrv Measles Shots in Children Under 5 Years of Age

THOMSON REUTERS
·
18 Jun

Moderately bullish activity in Moderna with shares up 0.88%

TIPRANKS
·
18 Jun

US Cdc's Advisory Committee on Immunization Practices to Vote on Thimerosal Containing Influenza Vaccine Recommendations

THOMSON REUTERS
·
18 Jun

US Cdc Discloses Agenda for June 25-26 Vaccine Expert Panel Meeting - Website

THOMSON REUTERS
·
18 Jun

Option traders moderately bearish in Moderna with shares down 0.75%

TIPRANKS
·
18 Jun

Trump Says Pharma Tariffs Coming Very Soon

Reuters
·
17 Jun

Moderna’s mRESVIA Vaccine Faces Market Challenges Despite FDA Approval

TIPRANKS
·
16 Jun

Sector Update: Health Care Stocks Lean Lower Premarket Friday

MT Newswires Live
·
13 Jun

Bernstein Sticks to Its Hold Rating for Moderna (MRNA)

TIPRANKS
·
13 Jun

Piper Sandler Remains a Buy on Moderna (MRNA)

TIPRANKS
·
13 Jun

Moderna - Intends to Have Mresvia Available for Younger Adults at Increased Risk and Older Adults in the U.S. for 2025-2026 Respiratory Virus Season

THOMSON REUTERS
·
13 Jun

Moderna Receives U.S. FDA Approval for Rsv Vaccine, Mresvia, in Adults Aged 18–59 at Increased Risk for Rsv Disease

THOMSON REUTERS
·
13 Jun

Moderna Secures FDA Approval for RSV Vaccine mRESVIA for At-Risk Adults Aged 18-59

Reuters
·
13 Jun

Moderna Director Hussain Abbas Reports Disposal of Common Shares

Reuters
·
13 Jun

BUZZ-Moderna falls, seeks partners for certain vaccine studies

Reuters
·
13 Jun

BUZZ-BMO says CDC panel replacements read negative for vaccine makers

Reuters
·
12 Jun